John Lunger - Net Worth and Insider Trading

John Lunger Net Worth

The estimated net worth of John Lunger is at least $15,689 dollars as of 2024-11-05. John Lunger is the Chief Patient Supply Officer of Adaptimmune Therapeutics PLC and owns about 19,015 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $15,689. Details can be seen in John Lunger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Lunger has not made any transactions after 2024-01-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John Lunger

To

John Lunger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Lunger owns 3 companies in total, including Adaptimmune Therapeutics PLC (ADAP) , Genocea Biosciences Inc (GNCAQ) , and Genocea Biosciences Inc (GGNNQ) .

Click here to see the complete history of John Lunger’s form 4 insider trades.

Insider Ownership Summary of John Lunger

Ticker Comapny Transaction Date Type of Owner
ADAP Adaptimmune Therapeutics PLC 2024-01-17 Chief Patient Supply Officer
GNCAQ Genocea Biosciences Inc 2022-03-03 director
GGNNQ Genocea Biosciences Inc 2022-03-03 director

John Lunger Latest Holdings Summary

John Lunger currently owns a total of 1 stock. John Lunger owns 19,015 shares of Adaptimmune Therapeutics PLC (ADAP) as of January 17, 2024, with a value of $15,689.

Latest Holdings of John Lunger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADAP Adaptimmune Therapeutics PLC 2024-01-17 19,015 0.83 15,689

Holding Weightings of John Lunger


John Lunger Form 4 Trading Tracker

According to the SEC Form 4 filings, John Lunger has made a total of 17 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 22,795 shares on January 17, 2024, which brought John Lunger around $15,957.

Insider Trading History of John Lunger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Lunger Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Lunger Ownership Network

Ownership Network List of John Lunger

No Data

Ownership Network Relation of John Lunger

Insider Network Chart

John Lunger Owned Company Details

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

John Lunger is the Chief Patient Supply Officer of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, John Lunger made 3 insider transaction in Adaptimmune Therapeutics PLC (ADAP) with a net sale of 35,120. Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 73,322 shares made by Adrian Rawcliffe , a net sale of 32,818 shares made by Bertrand William C Jr , and a net sale of 32,371 shares made by Elliot Norry .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 245,864 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 245,864 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

John Lunger Mailing Address

Above is the net worth, insider trading, and ownership report for John Lunger. You might contact John Lunger via mailing address: C/o Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park, Abingdon, Oxfordshire X0 Ox14 4rx.